TP53 and neoplasm: However, as highlighted throughout this review, sub-lethal activation of p53 may paradoxically promote tumour progression by activating anti-apoptotic proteins, autophagy, alternative cell death pathways as well as cellular senescence (reviewed in [206]) with tumour promoting properties that may in turn confer resistance to p53 activating therapies such as chemotherapy.